112 related articles for article (PubMed ID: 12641623)
1. Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus.
Dane-Stewart CA; Watts GF; Barrett PH; Stuckey BG; Mamo JC; Martins IJ; Redgrave TG
Clin Endocrinol (Oxf); 2003 Apr; 58(4):415-20. PubMed ID: 12641623
[TBL] [Abstract][Full Text] [Related]
2. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
[TBL] [Abstract][Full Text] [Related]
3. Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity.
Chan DC; Watts GF; Barrett PH; Mamo JC; Redgrave TG
Clin Chem; 2002 Feb; 48(2):278-83. PubMed ID: 11805008
[TBL] [Abstract][Full Text] [Related]
4. Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia.
Dane-Stewart CA; Watts GF; Mamo JC; Barrett PH; Martins IJ; Dimmitt SB; Redgrave TG
Eur J Clin Invest; 2002 Jul; 32(7):493-9. PubMed ID: 12153549
[TBL] [Abstract][Full Text] [Related]
5. Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
Redgrave TG; Watts GF; Martins IJ; Barrett PH; Mamo JC; Dimmitt SB; Marais AD
J Lipid Res; 2001 May; 42(5):710-5. PubMed ID: 11352977
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ
Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test.
Chan DC; Watts GF; Barrett PH; Martins IJ; James AP; Mamo JC; Mori TA; Redgrave TG
J Lipid Res; 2002 May; 43(5):706-12. PubMed ID: 11971941
[TBL] [Abstract][Full Text] [Related]
8. Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity.
Watts GF; Chan DC; Barrett PH; Martins IJ; Redgrave TG
Clin Sci (Lond); 2001 Dec; 101(6):683-90. PubMed ID: 11724657
[TBL] [Abstract][Full Text] [Related]
9. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.
Björkegren J; Silveira A; Boquist S; Tang R; Karpe F; Bond MG; de Faire U; Hamsten A
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1470-4. PubMed ID: 12231568
[TBL] [Abstract][Full Text] [Related]
10. Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes?
Phillips C; Madigan C; Owens D; Collins P; Tomkin GH
Int J Exp Diabetes Res; 2002; 3(3):171-8. PubMed ID: 12458658
[TBL] [Abstract][Full Text] [Related]
11. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M
Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons.
Wajchenberg BL; Amâncio RF; Santomauro AT; Maranhão RC
Clin Endocrinol (Oxf); 2004 Sep; 61(3):347-52. PubMed ID: 15355451
[TBL] [Abstract][Full Text] [Related]
13. Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test.
Watts GF; Barrett PH; Marais AD; Dane-Stewart CA; Martins IJ; Dimmitt SB; Redgrave TG
Atherosclerosis; 2001 Aug; 157(2):519-23. PubMed ID: 11472755
[TBL] [Abstract][Full Text] [Related]
14. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
15. Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome.
Chan DC; Watts GF; Barrett PH; O'Neill FH; Redgrave TG; Thompson GR
Clin Sci (Lond); 2003 Apr; 104(4):383-8. PubMed ID: 12653682
[TBL] [Abstract][Full Text] [Related]
16. Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
Chan DC; Wong AT; Pang J; Barrett PH; Watts GF
Clin Sci (Lond); 2015 Mar; 128(6):379-85. PubMed ID: 25291660
[TBL] [Abstract][Full Text] [Related]
17. Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes.
Phillips C; Murugasu G; Owens D; Collins P; Johnson A; Tomkin GH
Atherosclerosis; 2000 Feb; 148(2):283-91. PubMed ID: 10657563
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
Chan DC; Watts GF; Redgrave TG; Mori TA; Barrett PH
Metabolism; 2002 Aug; 51(8):1041-6. PubMed ID: 12145779
[TBL] [Abstract][Full Text] [Related]
19. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Chan DC; Watts GF; Nguyen MN; Barrett PH
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
[TBL] [Abstract][Full Text] [Related]
20. Relationships in women between body mass index and the intravascular metabolism of chylomicron-like emulsions.
Oliveira MR; Maranhão RC
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1471-8. PubMed ID: 15486570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]